Skip to content
No results
Home
About
Executive Team
Board of Directors
Strategic Collaborations
Careers
Products
Zabadinostat (CXD101)
AT-101
PCV-001
Press Releases
Pipeline
Publications
Contact
Home
About
Executive Team
Board of Directors
Strategic Collaborations
Careers
Products
Zabadinostat (CXD101)
AT-101
PCV-001
Press Releases
Pipeline
Publications
Contact
Search
Menu
ASH Dec 16 Poster 2
December 10, 2016
ASH-Dec-2016-Poster-2
Share This Post
X
Facebook
LinkedIn
Messenger
WhatsApp
Posts navigation
← ASH Dec 16 Poster 1
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism →
More Posts
Interim Phase 2 Results Suggest Zabadinostat Combination Improves Overall Survival in Advanced Liver Cancer
February 26, 2025
IngenOx Therapeutics Chief Medical Officer Meets Chinese Premier to Advance International Anti-Cancer Cooperation
February 10, 2025
IngenOx Therapeutics CMO Receives China Friendship Medal
October 21, 2024
